Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies
Atherosclerosis, a chronic inflammatory disease, remains a leading cause of cardiovascular mortality worldwide. Despite standard treatments like statins and percutaneous coronary intervention (PCI), significant residual risk and therapeutic limitations underscore the need for innovative strategies....
Saved in:
| Main Authors: | Dorota Bartusik-Aebisher, Rafał Podgórski, Iga Serafin, David Aebisher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1720 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticles for Glioblastoma Treatment
by: Dorota Bartusik-Aebisher, et al.
Published: (2025-05-01) -
Application of therapeutical nanoparticles with neutrophil membrane camouflaging for inflammatory plaques targeting against atherosclerosis
by: Ningnannan Zhang, et al.
Published: (2025-02-01) -
Visualization of Atherosclerotic Plaques Paired with Joheksol 350 (Omnipaque)
by: Piotr Wańczura, et al.
Published: (2025-02-01) -
Targeted drug delivery systems for atherosclerosis
by: Liangxing Tu, et al.
Published: (2025-04-01) -
Recent Advances in Nanozymes for the Treatment of Atherosclerosis
by: Zou Z, et al.
Published: (2025-07-01)